These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22954429)

  • 1. What is the most promising treatment for Parkinson's disease: genes, cells, growth factors or none of the above?
    Cummins G; Barker RA
    Regen Med; 2012 Sep; 7(5):617-21. PubMed ID: 22954429
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of Parkinson's disease pathophysiology for the development of cell replacement strategies and drug discovery in neurodegenerative diseases.
    Pan-Montojo F; Funk RH
    CNS Neurol Disord Drug Targets; 2012 Nov; 11(7):907-20. PubMed ID: 23131153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Skin-credible: skin cells used to generate neurons damaged by Parkinson’s disease.
    Regen Med; 2012 Sep; 7(5):631-2. PubMed ID: 22954432
    [No Abstract]   [Full Text] [Related]  

  • 4. Dopaminergic neurons for Parkinson's therapy.
    Lindvall O
    Nat Biotechnol; 2012 Jan; 30(1):56-8. PubMed ID: 22231097
    [No Abstract]   [Full Text] [Related]  

  • 5. Trophic factor gene therapy for Parkinson's disease.
    Kordower JH; Bjorklund A
    Mov Disord; 2013 Jan; 28(1):96-109. PubMed ID: 23390096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated astrocytes enhance the dopaminergic differentiation of stem cells and promote brain repair through bFGF.
    Yang F; Liu Y; Tu J; Wan J; Zhang J; Wu B; Chen S; Zhou J; Mu Y; Wang L
    Nat Commun; 2014 Dec; 5():5627. PubMed ID: 25517983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of stem cells in regenerative medicine for Parkinson's and Huntington's Diseases.
    Lescaudron L; Naveilhan P; Neveu I
    Curr Med Chem; 2012; 19(35):6018-35. PubMed ID: 22963567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progranulin gene delivery protects dopaminergic neurons in a mouse model of Parkinson's disease.
    Van Kampen JM; Baranowski D; Kay DG
    PLoS One; 2014; 9(5):e97032. PubMed ID: 24804730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of growth factors for the treatment of Parkinson's disease.
    Yasuda T; Mochizuki H
    Expert Rev Neurother; 2010 Jun; 10(6):915-24. PubMed ID: 20518608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell therapies for Parkinson's disease: are trials just around the corner?
    Drouin-Ouellet J; Barker RA
    Regen Med; 2014; 9(5):553-5. PubMed ID: 25372072
    [No Abstract]   [Full Text] [Related]  

  • 11. Towards stem cell based therapies for Parkinson's disease.
    Parmar M
    Development; 2018 Jan; 145(1):. PubMed ID: 29311261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell therapy for Parkinson's disease: Functional role of the host immune response on survival and differentiation of dopaminergic neuroblasts.
    Wenker SD; Leal MC; Farías MI; Zeng X; Pitossi FJ
    Brain Res; 2016 May; 1638(Pt A):15-29. PubMed ID: 26239914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improvement of neurological dysfunctions in aphakia mice, a model of Parkinson's disease, after transplantation of ES cell-derived dopaminergic neuronal precursors.
    Chung S; Moon J; Kim KS
    Methods Mol Biol; 2014; 1213():285-91. PubMed ID: 25173391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Embryonic stem cells go from bench to bedside for Parkinson's disease.
    Parish CL; Thompson LH
    Cell Rep Med; 2021 Apr; 2(4):100251. PubMed ID: 33948581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical translation of stem cell transplantation in Parkinson's disease.
    Lindvall O
    J Intern Med; 2016 Jan; 279(1):30-40. PubMed ID: 26332959
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Rescue of Dopaminergic Neuron Loss in Parkinson's Disease Mice After Transplantation of Hematopoietic Stem and Progenitor Cells.
    Altarche-Xifro W; di Vicino U; Muñoz-Martin MI; Bortolozzi A; Bové J; Vila M; Cosma MP
    EBioMedicine; 2016 Jun; 8():83-95. PubMed ID: 27428421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The bioengineering of stem cells to create dopamine replacement neurons is not the solution for Parkinson's.
    Carey RJ; Carey JL
    Pharmacol Biochem Behav; 2017 Dec; 163():36-37. PubMed ID: 29066358
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
    Chen W; Huang Q; Ma S; Li M
    ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balancing Expectations for Success in Stem Cell-Based Clinical Trials for Parkinson's Disease.
    Lindvall O
    Cell Stem Cell; 2020 Oct; 27(4):519-522. PubMed ID: 33007236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human Trials of Stem Cell-Derived Dopamine Neurons for Parkinson's Disease: Dawn of a New Era.
    Barker RA; Parmar M; Studer L; Takahashi J
    Cell Stem Cell; 2017 Nov; 21(5):569-573. PubMed ID: 29100010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.